Actinium Pharmaceuticals, Inc.
ATNM· NYSE
ATNMActinium Pharmaceuticals, Inc.
Filed Apr 12, 2012 · 10-K · 103 days after period end · 0001078782-12-001008
| Metric | Q4 2011 | Q4 2010dderived from reported figures |
|---|---|---|
| Revenue | $0.00 | $0.00 |
| Net Income | -$4.01K | -$477.46K |
| EPS Diluted | -$0.01 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Actinium Pharmaceuticals, Inc. · CIK 1388320 · Engraved from SEC EDGAR
ended Dec 31, 2011 · filed Apr 12, 2012 · 103 d after period end
